SUNPHARMA · Sun Pharmaceutical Industries Limited · Financials
Volume · Nov 12
105.95K
Avg daily vol (13 sessions)
103.08K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
584.62B
+11.2%
FY2026
Net Income
114.79B
+5%
FY2026
Operating Cash Flow
124.19B
-11.7%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| INR | 616.31B | 584.62B | 525.78B | 484.97B | 438.86B | 386.54B | 334.98B | 328.38B | 290.66B | 264.89B |
| INR | 30.05B | 29.38B | 25.75B | 25.57B | 25.29B | 21.44B | 20.8B | 20.53B | 17.53B | 15B |
| INR | 3.39B | 3.39B | 2.31B | 2.38B | 1.72B | 1.27B | 1.41B | 3.03B | 5.55B | 5.18B |
| INR | 39.99B | 35.54B | 27.72B | 14.39B | 8.48B | 10.76B | 5.15B | 8.23B | 6.01B | 8.45B |
| INR | 109.66B | 114.79B | 109.29B | 95.76B | 84.74B | 32.73B | 29.04B | 37.65B | 26.65B | 21.62B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 151.45B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.